These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 8438489

  • 1. OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics.
    Henell KR, Cheever JM, Kimball JA, Lye WC, Munar MY, Misiti J, Vitow C, Norman DJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):800-1. PubMed ID: 8438489
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. OKT3 antibody response study: comparative testing of human antimouse antibody.
    Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, Wall W.
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):74-6. PubMed ID: 8465432
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H, Hamano K, Fukumoto T, Wood KJ, Esato K.
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival.
    Lucien J, Marath A, Rayat G, Thliveris J, Koshal A, Yatscoff R.
    Transplant Proc; 1996 Apr; 28(2):704-7. PubMed ID: 8623356
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selection and chimerization of a monoclonal CD4 antibody for heart transplantation.
    Reiter C, Meiser BM, Uberfuhr P, Wenke K, Reichenspurner H, Kreuzer E, Rieber EP, Riethmüller G, Reichart B.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):788-9. PubMed ID: 8438481
    [No Abstract] [Full Text] [Related]

  • 13. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T, Knoop CJ, Hesse CJ, Vaessen LM, Balk AH, Yzermans JN, Weimar W.
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract] [Full Text] [Related]

  • 14. Donor-specific transplantation unresponsiveness in sensitized rats following treatment with a nondepleting anti-CD4 MAb is associated with selective intragraft sparing of Th2-like cells.
    Binder J, Hancock WW, Wasowska B, Gallon L, Watschinger B, Sayegh MH, Brock J, Lehmann M, Volk HD, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb; 27(1):114-6. PubMed ID: 7878825
    [No Abstract] [Full Text] [Related]

  • 15. Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival.
    Wee S, Kawai T, Knowles R, Colvin R, Cosimi AB.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):794-5. PubMed ID: 8438484
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC, Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J, Davis J, Bracht M, Carton J, Armstrong J, Gao W, Scallon B, Fung R, Emmell E, Zimmerman M, Griswold DE, Li L.
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppression with monoclonal anti-T3 antibody (WT32) in renal transplantation.
    Tax WJ, van de Heijden HM, Willems HW, Hoitsma AJ, Berden JH, Capel PJ, Koene RA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1905-7. PubMed ID: 3274448
    [No Abstract] [Full Text] [Related]

  • 20. Biological characteristics of a novel immunosuppressant, IR-1116, specific for B lymphocytes.
    Matsumoto S, Marui S, Shiho O, Tsukamoto K, Yoshimura N, Oka T.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):734-7. PubMed ID: 8382385
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.